Search Results - "Manjelievskaia, J"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    ADHERENCE AND PERSISTENCE AMONG HEREDITARY ANGIOEDEMA PATIENTS TREATED WITH BEROTRALSTAT, LANADELUMAB, AND SUBCUTANEOUS PLASMA-DERIVED C1-INHIBITOR by Zuraw, B., Lopez-Gonzalez, L., Winer, I., Dean, A., Manjelievskaia, J., Nestler-Parr, S., Gillard, P., Christiansen, S.

    Published in Annals of allergy, asthma, & immunology (01-11-2024)
    “…Berotralstat is a novel, targeted oral long-term prophylactic (LTP) treatment for hereditary angioedema (HAE). Real-world evidence comparing WAO/EAACI…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study by Varnado, Oralee J, Manjelievskaia, Janna, Ye, Wenyu, Perry, Allison, Schuh, Kory, Wenzel, Richard

    Published in Patient preference and adherence (01-01-2022)
    “…Most conventional, oral, preventive treatments for migraine are non-specific and ~50% of patients discontinue them within six months. In 2018, the Food and…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs by Llanos, Jean-Pierre, Ortega, Hector, Bogart, Michael, Packnett, Elizabeth R, Manjelievskaia, Janna, Bell, Christopher F, Hahn, Beth

    Published in Journal of asthma and allergy (01-01-2020)
    “…Results from clinical trials in patients with severe eosinophilic asthma have demonstrated that mepolizumab is well tolerated and is associated with improved…”
    Get full text
    Journal Article